CRISPR/Cas9 for overcoming drug resistance in solid tumors
Crossref DOI link: https://doi.org/10.1007/s40199-019-00240-z
Published Online: 2019-01-21
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Saber, Ali
Liu, Bin
Ebrahimi, Pirooz
Haisma, Hidde J.
Text and Data Mining valid from 2019-01-21
Version of Record valid from 2019-01-21
Article History
Received: 30 October 2018
Accepted: 4 January 2019
First Online: 21 January 2019
Compliance with ethical standards
:
: The authors declare that they have no competing interests.